Jiangsu Hansoh Pharmaceutical Group Company Limited
Jiangsu Hansoh Pharmaceutical Group Company Limited (China) holds 17 active US FDA Type II Drug Master Files and 3 inactive, has DMF or CEP filings on record for 15 active ingredients and is linked to 1 FDA-registered manufacturing site. No FDA recall, Warning Letter or Form 483 record is linked to it, which is not proof that none exists.
Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records
Cite as: PharmaTek, “Jiangsu Hansoh Pharmaceutical Group Company Limited: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/jiangsu-hansoh-pharmaceutical-group-company-limited
Overview
Jiangsu Hansoh Pharmaceutical Group Company Limited is a leading pharmaceutical company in China, specializing in the research, development, manufacturing, and marketing of a variety of drugs. The company focuses on therapeutic areas such as oncology, infectious diseases, and diabetes management.
Core services & business areas
Therapeutic areas
Active ingredients with DMF or CEP filings
Substances for which Jiangsu Hansoh Pharmaceutical Group Company Limited holds, or has held, a US FDA Drug Master File or an EU CEP. A filing is not proof of current supply. Open any ingredient to see all its holders, CAS number and product patent dates.
API / Drug Master Files
Jiangsu Hansoh Pharmaceutical Group Company Limited holds 17 active (20 total) FDA Type II Drug Master Files. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.
- CARFILZOMIB, NON-STERILE, BULK DRUG SUBSTANCEActive2025-03-10
- HS-20098Active2024-09-05
- PEMETREXED DISODIUM USP NON-STERILEActive2022-06-15
- DEGARELIX ACETATE NON-STERILE BULK DRUG SUBSTANCEActive2022-01-27
- MICAFUNGIN SODIUMActive2022-01-20
- NINTEDANIB ESYLATE, NON-STERILE, BULK DRUG SUBSTANCEActive2019-12-20
- FULVESTRANT USP, NON-STERILE BULK DRUG SUBSTANCEActive2019-09-05
- MICAFUNGIN SODIUMActive2018-12-14
- AZACITIDINE, NON-STERILE BULK DRUG SUBSTANCEActive2018-09-21
- DECITABINE, NON-STERILE BULK DRUG SUBSTANCEActive2018-05-21
- BORTEZOMIBActive2018-01-19
- DAPAGLIFLOZINActive2017-11-21
- VINORELBINE TARTRATE, USPActive2017-04-13
- GEMCITABINE HYDROCHLORIDE USPActive2017-03-24
- ICATIBANT ACETATEActive2016-12-16
- PEMETREXED DISODIUM HEMIPENTAHYDRATE, NON-STERILE, BULK DRUG SUBSTANCEActive2015-06-10
- PEMETREXED DIACID, NON-STERILE, BULK DRUG SUBSTANCEActive2014-12-08
- OLANZAPINE USP, NON-STERILEInactive2016-01-28
- GEMCITABINE HYDROCHLORIDE USP (NON-STERILE BULK DRUG SUBSTANCE)Inactive2005-09-24
- VINORELBINE TARTRATE USPInactive2002-06-14
Registered manufacturing sites (1)
Physical sites registered with the US FDA and resolved to Jiangsu Hansoh Pharmaceutical Group Company Limited, with any EU/UK GMP documents matched to each site. Headquarters and manufacturing locations can differ.
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Jiangsu Hansoh Pharmaceutical Group Company Limited in our records. Events are linked by company name and identifier, so this is not proof that none exist; check the FDA's own databases before relying on it.
Is this Jiangsu Hansoh Pharmaceutical Group Company Limited?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.
Need suppliers found and checked?
The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.